Suicidal Ideation in Medicinal Cannabis Patients: A 12-Month Prospective Study.

Michael T Nurmohamed Hannah Thurgur Alkyoni Athanasiou-Fragkouli Anne Katrin Schlag David John Nutt

Published in: Archives of suicide research : official journal of the International Academy for Suicide Research (2024)

SI is common among individuals seeking CBMPs to treat a range of chronic conditions and is associated with higher levels of depressed mood and poorer quality of life. Treatment with CBMPs reduced the prevalence and intensity of suicidal ideation.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
bipolar disorder
prognostic factors
mental health
risk factors
high intensity
room temperature
sleep quality
patient reported
combination therapy